// App-Quantinova.ai

EP30 : Understanding which patient-reported outcomes are important to rheumatology patients: findings from ArthritisPower

Researchers

Presenter

  • Tariq Daud

Principal Investigators

  • William B Nowell

  • Carol L Kannowski

  • Kelly Gavigan

  • Zhihong Cai

  • Anabela Cardoso

  • Theresa Hunter

  • Julie Birt

  • Jennifer Workman

  • Jeffrey Curtis

Medical Centers

  • Medical Affairs, Eli Lilly and Company, Basingstoke, UNITED KINGDOM

  • Patient-Centered Research at CreakyJoints, Global Healthy Living Foundation, Nyack, NY, USA

  • GPORWE-Bio-Medicines, Eli Lilly and Company, Indianapolis, IN, USA

  • Research and Data Science, Global Healthy Living Foundation, Nyack, NY, USA

  • Eli Lilly Japan, Eli Lilly and Company, Tokyo, JAPAN

  • Eli Lilly and Company, Eli Lilly and Company, Indianapolis, IN

  • Medical Center, University of Alabama at Birmingham, Birmingham, AL, USA

Locations

  • United Kingdom

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Osteoarthritis

  • Osteoporosis

  • Fibromyalgia

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved